| CAS NO: | 681159-27-3 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| 生物活性 | CBR-5884 is an active, selective inhibitor ofphosphoglycerate dehydrogenase (PHGDH)with anIC50of 33 μM. CBR-5884 inhibits de novoserine synthesisincancercells and is selectively toxic tocancercell lines with high serine biosynthetic activity. CBR-5884 selectively inhibits the proliferation of melanoma and breastcancerlines that have a high propensity for serine synthesis[1]. | ||||||||||||||||
| IC50& Target | PHGDH, serine synthesis[1] | ||||||||||||||||
| 体外研究 (In Vitro) | CBR-5884 (15 or 30 μM; 3-5 days) selectively inhibits the proliferation of melanoma and breast cancer lines that have a high propensity for serine synthesis. Cell Proliferation Assay[1]
| ||||||||||||||||
| 分子量 | 336.39 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C14H12N2O4S2 | ||||||||||||||||
| CAS 号 | 681159-27-3 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 50 mg/mL(148.64 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |
